Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,236 | 68,271 | 76,516 | 54,837 | 25,910 |
| Depreciation Amortization | 2,503 | 5,615 | 2,664 | 1,611 | 837 |
| Income taxes - deferred | -2,851 | 3,556 | 322 | 322 | N/A |
| Accounts receivable | -1,891 | 3,054 | -6,240 | -1,446 | 4,376 |
| Accounts payable and accrued liabilities | 6,374 | 595 | 804 | 4,931 | 1,456 |
| Other Working Capital | -11,717 | -34,773 | -21,525 | -6,091 | 4,322 |
| Other Operating Activity | 1,810 | -29,656 | -22,063 | -20,628 | -11,593 |
| Operating Cash Flow | $-18,008 | $16,662 | $30,478 | $33,536 | $25,308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -80,698 | 38,004 | 37,505 | -15,923 | -31,655 |
| PPE Investments | -41 | -591 | -533 | -321 | -334 |
| Purchase Sale Intangibles | N/A | -53,111 | -52,139 | N/A | N/A |
| Other Investing Activity | 0 | -53,111 | -52,139 | 0 | 0 |
| Investing Cash Flow | $-80,739 | $-15,698 | $-15,167 | $-16,244 | $-31,989 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 143,750 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,911 | 404 | 376 | 376 | N/A |
| Common Stock Repurchased | -18,000 | -22,361 | -16,707 | -13,081 | N/A |
| Other Financing Activity | -5,746 | -1,361 | -961 | -653 | -406 |
| Financing Cash Flow | $122,915 | $-23,318 | $-17,292 | $-13,358 | $-406 |
| Exchange Rate Effect | 179 | -297 | 215 | 358 | 108 |
| Beginning Cash Position | 16,564 | 39,215 | 39,215 | 39,215 | 39,215 |
| End Cash Position | 40,911 | 16,564 | 37,449 | 43,507 | 32,236 |
| Net Cash Flow | $24,347 | $-22,651 | $-1,766 | $4,292 | $-6,979 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,008 | 16,662 | 30,478 | 33,536 | 25,308 |
| Capital Expenditure | -41 | -591 | -533 | -321 | -334 |
| Free Cash Flow | -18,049 | 16,071 | 29,945 | 33,215 | 24,974 |